Evaluation of the efficacy and safety of Transdermal fentanyl in patients suffering from chronic cancer pain in an ambulatory setting.
Phase of Trial: Phase III
Latest Information Update: 12 Mar 2009
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 12 Mar 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 12 Mar 2009 Actual patient number (34) added as reported by ClinicalTrials.gov.
- 12 Mar 2009 Planned end date (1 May 2004) added as reported by ClinicalTrials.gov.